Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05610267
Other study ID # T-GENVIH-002
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 22, 2022
Est. completion date December 28, 2022

Study information

Verified date June 2024
Source Integra LifeSciences Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to collect additional safety data and demonstrate the performance of Integra Gentrix® Surgical Matrix for reinforcement of ventral hernia repairs.


Description:

Retrospective data will be collected and assessed for early post-operative surgical site events and complications in the immediate post-operative period of 90 days.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date December 28, 2022
Est. primary completion date December 28, 2022
Accepts healthy volunteers No
Gender All
Age group 22 Years to 80 Years
Eligibility Inclusion Criteria: 1. Patients between 22 years and 80 years old (inclusive) at time they underwent abdominal wall reconstruction utilizing Gentrix® Surgical Matrix as a reinforcement graft during the time period between November 1, 2017, and present (90 days prior to the start of the data collection).. 2. Subject underwent abdominal wall reconstruction for a hernia(s) using Integra® Gentrix® Surgical Matrix. Exclusion Criteria: 1. Subject has known allergy to porcine-derived products. 2. Subject required use of Gentrix® device and a second non-Gentrix surgical mesh in the same plane or in different planes for single hernia e.g., Gentrix sublay and a synthetic device in the onlay position. 3. Subject had active necrotizing fasciitis or any current known uncontrolled systemic infection. 4. Subject had uncontrolled diabetes, defined as Hb1AC value >7% within 12 weeks prior to index procedure. 5. Subject has been diagnosed with cirrhosis and/or ascites.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Retrospective chart review
The retrospective chart review will include the full consecutive series of patients between 22 years and 80 years old who underwent abdominal wall reconstruction for achart hernia with Integra Gentrix® Surgical Matrix during the time period between November 1, 2017, and present (90 days prior to the start of data collection).

Locations

Country Name City State
United States Surgical Healing Arts Center Fort Myers Florida

Sponsors (1)

Lead Sponsor Collaborator
Integra LifeSciences Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Average Length of Hospital Stay (LOS) Post Index Procedure (Measured in Days) Number of days between the date of the index procedure and the date of the hospital discharge 90 days
Other Rate of Opioid Usage Following Procedure Determined by % of Prescriptions Filled and Refilled Number of subjects who used opioids following the procedure based on the concomitants medication 90 days
Primary Incidence of Post-operative Complications Requiring Procedural Intervention Within 90 Days Post Index Procedure Percentage of subjects with a post-operative complications requiring procedural intervention within 90 days post index procedure 90 days
Secondary Incidence of Early Post-operative Complications (Surgical Site Occurrences (SSOs)) Within 90 Days Post Index Procedure Percentage of subjects with an early post-operative complications (Surgical Site Occurrences (SSOs)) within 90 days post index procedure 90 days
Secondary Incidence of Surgical Site Infections (SSIs) Post Index Procedure Percentage of subjects with Surgical Site Infections (SSIs) Post index procedure 90 days
Secondary Incidence of Later Post-operative Complications After 90 Days Post Index Procedure Percentage of subjects with a later post-operative complications after 90 days post index procedure 1 year
Secondary Incidence of Hernia Recurrence Confirmed by Clinical Assessment Percentage of subjects with a hernia recurrence confirmed by clinical assessment 1 year
Secondary Incidence of Reoperation Requirement Due to Index Repair Percentage of subjects with a reoperation requirement due to index repair 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT06016426 - Mass Closure vs Layer by Layer Closure N/A
Recruiting NCT05572021 - A Comparison of the Outcomes in Fortiva and Strattice Mesh N/A
Completed NCT02263625 - Regional Differences In Indication for Ventral Hernia Repair
Completed NCT02263599 - Conservative Treatment For Ventral Hernia
Completed NCT02292264 - Risk Factors and Complications of Ventral Hernia Repair
Completed NCT01961687 - A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair. N/A
Completed NCT01325246 - Reoperation Rate Versus Clinical Recurrence After Ventral Hernia Repair N/A
Completed NCT03283982 - Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM N/A
Not yet recruiting NCT05526209 - Longitudinal Relaxing Incision as a Technique for Recurrence Prevention in Ventral Hernia
Completed NCT04438369 - Evaluation of Ultrasound-guided Erector Spinae Block for Postoperative Analgesia in Laprascopic Ventral Hernia Repair. N/A
Recruiting NCT04173884 - Video-based Collaborative Learning to Improve Ventral Hernia Repair N/A
Recruiting NCT02703662 - Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction Phase 2/Phase 3
Completed NCT03938688 - Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation N/A
Completed NCT01719718 - The Influence of Closing the Gap on Postoperative Seroma and Recurrences in Laparoscopic Ventral Hernia Repair N/A
Completed NCT03342040 - Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair N/A
Completed NCT04150796 - Comparing eTEP and Laparoscopic Intraperitoneal Onlay Mesh (IPOM) for Ventral Hernias N/A
Recruiting NCT03222102 - Ventral Hernia Prevention After Liver Transplantation N/A
Terminated NCT01794338 - The Use of Biologic Mesh vs Bioabsorbable Mesh During Ventral Hernia Repair in At-risk Patients N/A
Completed NCT01886963 - A Clinical Trial Using Spy Elite System in Planning Tissue Advancement Flaps After Ventral Hernia Repair N/A
Terminated NCT03429374 - Tacks Versus Glue for Mesh Fixation in Laparoscopic Ventral Hernia Repair Treating Defects Between 2 and 5 cm Width N/A